Real-world evidence of the use of the infliximab biosimilar SB2: data from the PERFUSE study.
Bruno FautrelYoram BouhnikPhilippe DieudePascal RichetteMaxime DougadosUlrich FreudensprungAmira BriguiJanet AddisonPublished in: Rheumatology advances in practice (2023)
clinicaltrials.gov, NCT03662919.
Keyphrases